dc.contributor.author
Ehret, Felix
dc.contributor.author
Mose, Lucas
dc.contributor.author
Kufeld, Markus
dc.contributor.author
Fürweger, Christoph
dc.contributor.author
Windisch, Paul
dc.contributor.author
Haidenberger, Alfred
dc.contributor.author
Schichor, Christian
dc.contributor.author
Tonn, Jörg-Christian
dc.contributor.author
Muacevic, Alexander
dc.date.accessioned
2021-09-28T06:29:25Z
dc.date.available
2021-09-28T06:29:25Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/32078
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-31806
dc.description.abstract
Background Due to recent medical advancements, patients suffering from metastatic spinal disease have a prolonged life expectancy than several decades ago, and some will eventually experience relapses. Data for the retreatment of spinal metastasis recurrences occurring at the very same macroscopic spot as the initially treated lesion are limited. Previous studies mainly included recurrences in the boundary areas as well as other macroscopic parts of the initially affected vertebrae. This study exclusively analyzes the efficacy and safety of spinal reirradiation for recurrences on the same site utilizing single-session robotic radiosurgery.
Materials and Methods Patients between 2005 and 2020 who received radiotherapy for a spinal metastasis suffering from a local recurrence were eligible for analysis. Only patients undergoing a single-session reirradiation were included. All recurrences must have been occurred in the same location as the initial lesion. This was defined as a macroscopic recurrence on computed tomography occurring at the same site as the initial spinal metastasis. All other lesions, including those in the boundary areas or other parts of the initially affected vertebrae, were excluded.
Results Fifty-three patients with fifty-three lesions were retreated for spinal metastases. The median dose and number of fractions for the initial radiotherapy were 36 Gy and 15, respectively. Eleven patients were initially treated with stereotactic body radiotherapy. Retreatment was performed with a median dose of 18 Gy prescribed to a median isodose of 70%. The local control was 77% after a median follow-up of 22.2 months. Patients experiencing a second recurrence received a lower dose (p = 0.04), mostly below 18 Gy, and had a worse coverage (p = 0.01) than those showing local tumor control. 51% of patients experienced an improvement in pain control after treatment delivery. Besides, four vertebral compression fractures (7% of patients) but no other adverse events higher than grade 2 were observed.
Conclusion Single-session robotic radiosurgery appears to be a safe, time-saving, and effective treatment modality for spinal metastasis recurrences occurring in the same initial location if a considerable dose and coverage can be applied. Treatment results are comparable to reirradiated metastases in the boundary areas.
en
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
radiosurgery
en
dc.subject
spinal metastasis
en
dc.subject
reirradiation (ReRT)
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Image-Guided Robotic Radiosurgery for the Treatment of Same Site Spinal Metastasis Recurrences
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.articlenumber
642314
dcterms.bibliographicCitation.doi
10.3389/fonc.2021.642314
dcterms.bibliographicCitation.journaltitle
Frontiers in Oncology
dcterms.bibliographicCitation.originalpublishername
Frontiers Media SA
dcterms.bibliographicCitation.volume
11
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
34123794
dcterms.isPartOf.eissn
2234-943X